SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...
Enterprise software vendors can see the agentic train coming and are quickly investing to stay ahead of it. For CIOs, the evolution of AaaS will change not just how the tools are used, but how they're ...
Pinecone recently announced the public preview of Dedicated Read Nodes (DRN), a new capacity mode for its vector database ...
Cryptopolitan on MSN
Lighter users face withdrawal disruptions as the team remains silent
Perpetual's trading platform, Lighter, is currently experiencing technical withdrawal disruptions, according to reports from ...
The study identifies AI data centers as a fundamentally distinct category of electricity consumer. Traditional data centers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback